ANO2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68732
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: EPVSLEARLSRMHFHDSQRKVDYVLAYHYRKRGVHLAQGFPGHSLAIVSNGETGKEPHAGGPGDIELGPLDALEEERKEQREEFEHNLM
Reactivity Notes
Mouse 84%, Rat 85%
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ANO2 Antibody
Immunohistochemistry-Paraffin: ANO2 Antibody [NBP2-68732]
Immunohistochemistry-Paraffin: ANO2 Antibody [NBP2-68732] - Staining of human liver shows no positivity in hepatocytes as expected.Applications for ANO2 Antibody
Application
Recommended Usage
Immunohistochemistry
1:1000 - 1:2500
Immunohistochemistry-Paraffin
1:1000 - 1:2500
Application Notes
Recommended conditions for IHC,Retrieval method: HIER pH6
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ANO2
Alternate Names
anoctamin 2, anoctamin-2, DKFZp434P102, TMEM16B, transmembrane protein 16B (eight membrane-spanning domains)
Gene Symbol
ANO2
Additional ANO2 Products
Product Documents for ANO2 Antibody
Product Specific Notices for ANO2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...